Heart disease remains the world's leading cause of illness and death, yet the familiar risk calculators can misjudge some people. A computer trained on many kinds of health information may offer a better warning. Atherosclerotic cardiovascular disease includes heart attacks, deaths from coronary heart disease, and strokes, and it has become the leading cause of illness and death worldwide.

Finding people at high risk matters because prevention works best before the first event. But personalized cardiovascular risk assessment remains a challenge in clinical practice. Guidelines recommend risk calculators, but widely used tools were built mainly from populations unlike many people in China, and overestimation or underestimation has been reported.

A calculator designed for Chinese adults still needs more evidence across different populations. So the study set out to predict cardiovascular disease in a general community population in Northeast China using demographic, behavioral, psychological, heart-tracing, and heart-imaging information.

It then compared machine-learning approaches with the traditional risk calculations to see which provided better predictions. The information included everyday facts such as age, sex, blood pressure, body size, lifestyle, and blood tests, along with hundreds of measurements from heart tracings and several from heart imaging.

The selection process worked like sorting a crowded toolbox: it repeatedly removed tools that added little and kept the measurements that carried the most useful information. Several machine-learning classifiers were trained on eighty percent of the dataset, with the remaining twenty percent reserved for testing.

The study then evaluated these machine-learning risk models alongside the usual calculators, including PCE and China-PAR, using several performance measures. The comparison asked not only whether the models separated higher-risk from lower-risk people, but also whether their estimated risks matched what actually happened and whether they could support better decisions.

After reducing the information to thirty key predictors, the artificial neural network performed better than the other machine-learning approaches in both separating risk levels and keeping its predictions consistent. Its overall prediction score was higher than the scores of the Chinese and conventional calculators.

The practical question is whether using these risk estimates would help clinicians make better decisions than treating everyone the same. Across likely high-risk cutoffs, the machine-learning approaches and established risk tools provide broadly similar, modest added benefit, so their real-world advantage may be limited.

In this Northeast China population, the established calculators separated higher-risk from lower-risk people reasonably well, but their predicted levels did not match reality closely enough. The artificial-neural-network model using thirty clinical variables performed better than those calculators, even after the calculators were adjusted for this population.

That suggests machine learning could improve risk prediction, although further studies are needed before it can strengthen clinical decisions. The model cannot show the separate effect of each variable or easily identify which treatment would reduce one persons risk, and longer follow-up is needed for a disease that develops over time.

Its accuracy also still needs testing in different populations, and changing blood pressure or blood sugar during follow-up was not taken into account. In this Chinese community population, the strongest machine-learning approach predicted future cardiovascular disease better than the usual calculators, though it still needs testing in other populations before changing care.